Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$12.19 - $28.17 $447,373 - $1.03 Million
-36,700 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$22.23 - $34.75 $75,737 - $118,393
-3,407 Reduced 8.49%
36,700 $890,000
Q4 2020

Feb 02, 2021

BUY
$29.47 - $35.0 $76,828 - $91,245
2,607 Added 6.95%
40,107 $1.29 Million
Q3 2020

Nov 05, 2020

BUY
$26.17 - $43.07 $268,922 - $442,587
10,276 Added 37.75%
37,500 $1.13 Million
Q2 2020

Aug 12, 2020

BUY
$22.3 - $44.8 $607,095 - $1.22 Million
27,224 New
27,224 $1.15 Million

Others Institutions Holding BDTX

About Black Diamond Therapeutics, Inc.


  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $94.1M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.